REASONS FOR JUDGMENT
1 The respondent, Interhealth Energies Pty Ltd (Interhealth) is the trustee of a fund held pursuant to superannuation trust deed and settled on 23 June 1993. The trust as constituted by that deed was comprehensively varied by a further deed on 25 November 1994 so as to align the trust with the requirements of the Superannuation Industry Supervision Act 1993 (Cth) (SIS Act). The trust is known as the Interhealth Superannuation Fund (the ISF). At all material times there were two members of this superannuation fund, Ms Joanna Hambrook (Ms Hambrook) and Mr Patrick Shaun Wilson (Mr Wilson). Ms Hambrook and Mr Wilson were once involved with each other both commercially and, via a de facto relationship, personally. The ISF was established in the course of each of these relationships. Each of these relationships ceased some time ago in what seems on the evidence to have been acrimonious circumstances. Ms Hambrook and Mr Wilson each gave evidence before me. To my direct observation, their antipathy one for the other was palpable, mutual and enduring. The wider origins of this proceeding lie in the cessation of these relationships, commercial and personal, and in that antipathy.
2 The more immediate origin of this proceeding is an undertaking given to the Commissioner of Taxation (the Commissioner) by Interhealth, by its by then remaining director, Ms Hambrook, on 28 February 2008 pursuant to s 262A of the SIS Act. That provision allows a "Regulator" to accept a written undertaking given by a person in connection with a matter in relation to which that "Regulator" has a function or power under the SIS Act. The Commissioner is Regulator, for the purpose of the application of the SIS Act to Self Managed Superannuation Funds (SMSF). The Commissioner alleges that this undertaking has been breached by Interhealth. He seeks orders that the undertaking be enforced.
3 Section 17A of the SIS Act defines what constitutes a SMSF for the purposes of that Act. Materially, such a fund must have fewer than five members and where, as here, its trustee is a body corporate, each director of the body corporate must be a member of the fund. Ms Hambrook remains a director of Interhealth. Mr Wilson ceased to be a director of that company on 7 October 2004. The effect of Mr Wilson's cessation of holding office as a director was that the Fund ceased to comply with a regulatory provision of the SIS Act namely, with the definition of self managed superannuation fund in s 17A. That, in turn, meant that the Fund could only meet the "compliance test" in s 42A of the SIS Act so as to constitute a complying superannuation fund if the Commissioner, as "Regulator", having regard to the matters specified in s 42A(5)(b) of the SIS Act, "thinks that a notice should nonetheless be given stating that the entity is a complying superannuation fund in relation to the year of income concerned".
4 Status as a complying superannuation fund has an important consequence for income tax purposes. A fund which has that status is subject to concessional rates of taxation whereas one which is not is taxed at the top marginal tax rate: Division 285 of the Income Tax Assessment Act 1997 (Cth) and, for the income years prior to the 2007/2008 year, Pt IX of the Income Tax Assessment Act 1936 (Cth).
5 It might perhaps be thought that there is a degree of tension between consigning to the Commissioner the function of "Regulator" with the power, relevantly, of granting a form of absolution to a fund from otherwise adverse fiscal consequences and his separate function as the Commonwealth's chief revenue collection officer. Equally though, given the benign taxation regime enjoyed by complying superannuation funds, consigning that duality of function to the Commissioner might be considered a means of ensuring fiscal integrity. It is neither necessary nor appropriate further to delve into, much less to resolve, matters of public administration practice. What it is necessary to record is that the giving of an undertaking under s 262A of the SIS Act is relevant to the exercise of the discretion under s 42A(5)(b) of that Act to give a notice that a fund is a complying fund in relation to a year of income.
6 Interhealth resists the making of any enforcement order at all, contending that there has been no breach of the undertaking and that, as a matter of discretion, relief should be refused on the basis that the Commissioner as Regulator has not, so it is contended, adopted an "even handed" approach to his administration of the SIS Act and has, by the institution of this proceeding, favoured Mr Wilson over Ms Hambrook. As will be apparent from these reasons for judgment, the latter submission is but symptomatic of a comprehensive failure by Ms Hambrook to understand and to cause Interhealth to discharge the duties that fell on it as the trustee of a SMSF both under the general law and under the SIS Act. All that the Commissioner has done on the evidence is in good faith to carry out his duties as Regulator under the SIS Act. Interhealth also advances alternative submissions, summarised below, that relief in the terms proposed by the Commissioner should not be granted.
7 Because of the direct interest which he had as a member in the outcome of the proceeding I granted leave to Mr Wilson to make submissions as to the form of orders which the Court might make in the event that I found that the undertaking had been breached and that an enforcement order ought to be made. Later, as a result of the supervening bankruptcy of Mr Wilson, this grant of leave was extended to his trustee in bankruptcy.
8 By the undertaking, Interhealth undertook to the Commissioner that it would do the following:
(a) collect payments of unpaid distributions owed to the ISF by the Greenhaven Unit Trust by 30 May 2008;
(b) pay to Mr Wilson his full superannuation entitlement by 30 May 2008; and
(c) provide evidence of the above to the Commissioner by 6 June 2008.
9 Given the denial by Interhealth of any breach of the undertaking, the primary issue in this proceeding is whether it has breached one or more of the requirements of the undertaking. A related issue is whether particular legal expenses incurred by Interhealth since the 2006 financial year are expenses properly incurred in the administration of the ISF. A further issue is whether Mr Wilson was entitled to benefits under the ISF deed as a lump sum in the 2006 year.
10 To understand how the undertaking came to be given in the terms set out above, whether it has been breached and how issues as to the incurring of legal expenses and as to Mr Wilson's entitlement in 2006 arise requires the making of detailed findings as to background facts. Before turning to this task it gives helpful context to make some reference to the duties of the trustee of a superannuation fund.
11 Used in a popular sense, the term "superannuation fund" means a retirement fund, especially one to which an employee and usually an employer make contributions during the period of employment so as to provide benefits after retirement (Macquarie Dictionary, Online Edition; Oxford English Dictionary, Online Edition). Just to refer to a "superannuation fund" can, by a conflation of a number of different concepts, be apt to distract from appreciating what, truly, are the legal entities involved, the legal relationships created and the trust property concerned. What in law occurs is the assumption of the office of trustee by a legal entity, in this case a body corporate, Interhealth, in respect of property settled on and accumulated by that trustee subject to particular trust obligations set out in a deed of trust. Strictly, the term "superannuation fund" refers not to the trustee but only to the property settled upon and accumulated by the trustee and held in terms of the trust. Further, a "superannuation fund" is not a legal entity, nor is "the trust" (although for revenue law purposes it is artificially treated as such). The only legal entity involved is the trustee.
12 Understanding this highlights that the duties which attend any trustee of property attend the office of trustee of a fund held on trust for the purposes of the provision of superannuation benefits. The price of benign taxation treatment for the assessable income of the fund is the assumption by its trustee of additional obligations, such as those for which the SIS Act provides. These supplement, rather than relieve a trustee from complying with, the general duties of a trustee. In the case of inconsistency, the SIS Act obligations prevail over whatever is otherwise specified in the governing trust deed.
13 A trustee's most fundamental duty is to comply with the terms of the trust. In the case of Interhealth its obligation is to comply with the terms of the deed governing the ISF, as varied. In discharging that duty, the trustee must act as would an ordinary, prudent man of business managing his own affairs: Re Speight (1882) 22 Ch D 727 at 739-740. As that deed is varied, Interhealth's obligation as trustee includes compliance with the SIS Act. A trustee is also subject to a range of fiduciary duties. These include a duty of impartiality. A trustee also has a duty to invest money held on trust. As varied, the deed governing the ISF confers a broad investment power on the trustee but expressly qualifies it in two ways (cl 9.1). The exercise of the investment power is subject to the provisions of the SIS Act. It is also subject to the proviso that trust investments are made on an arm's length basis. More generally, the exercise of that power is subject to the prudential management duty mentioned earlier. Subject to those express qualifications, that general requirement will dictate that the investment power be exercised in a way that is in the best financial interests of the beneficiaries of the trust: Cowan v Scargill [1985] Ch 270 at 286-287.
14 The trust property which has constituted the ISF has comprised liquid funds and, materially, the whole of the units in a unit trust known as the Greenhaven Unit Trust (GHUT) and an amount receivable from that trust by the ISF by way of unpaid distributions. Since October 2010 the trustee of the GHUT has been GHUT Holdings Pty Ltd of which Ms Hambrook is the sole director. Before then, Probiotic Technologies Pty Ltd (Probiotic) was the trustee of the GHUT. The worth, if any, of the units in the GHUT is controversial. Resolving that controversy requires an understanding of a complicated cascade of trust interests which ultimately find expression in an interest in land at Lot 6 Scenic Drive Bilambil in New South Wales (the Bilambil property). The nature of that cascade of trust interests, the entities which are trustees of the trusts concerned and who are presently the directors of those entities are best described diagrammatically, as set out below:
15 The Bilambil property was purchased in 2000 for the sum of $210,000 with the aid of funds advanced by Interhealth from the ISF to Probiotic, the then trustee of the GHUT, which also then acted and continues to act as the trustee of the Pelican Waters Unit Trust (PWUT). The PWUT was constituted in April 2000, inferentially in conjunction with the decision to acquire the Bilambil property. At the time of the purchase in 2000, the directors of Probiotic were Ms Hambrook and Mr Wilson. They were then on good terms both personally and commercially. In effecting the purchase of the Bilambil property as trustee Probiotic acted via Mr Wilson. On its acquisition, and for reasons which remain unclear, Mr Wilson chose to cause the Bilambil property to be registered in his name rather than that of Probiotic. Ms Hambrook was not then aware that this property had been so registered. The Bilambil property was though shown in the accounts of the PWUT as an asset of that trust on and from its acquisition.
16 A number of critical events occurred in 2004.
17 In March 2004 Probiotic sold 50% of the units in the PWUT to Tweed Mortgage and Investments Pty Ltd (TMI) for the sum of $200,000. TMI was then and remains a company controlled by Mr Ronald Williams and his American resident brother, Dr David Williams. TMI controlled Lot 2 at Scenic Drive. The proximity of that property to the Bilambil property and perceived future development benefits were a motivating factor for all parties in this PWUT unit sale transaction. The other attraction for Probiotic was that it converted part of the PWUT property namely, the Bilambil property, into liquid funds without having to dispose of that land. At the time of the transaction, the value of the Bilambil property had been appraised by a local real estate agency as being between $380,000 and $420,000. Probiotic struck its sale price by reference to this appraisal.
18 The directors of Probiotic as at the time of the sale of the units to TMI were Ms Hambrook and Mr Wilson. Contrary to Ms Hambrook's evidence, Mr Wilson denies participating in a meeting of directors of Probiotic on 25 March 2004 at which the sale of the units to TMI was approved. That a sale did occur as related in the preceding paragraph is undoubted.
19 Having regard to her later actions concerning the ISF and where Mr Wilson is concerned, I do not doubt that Ms Hambrook is well capable of expedient action in matters touching on her personal interest, even in circumstances which, viewed objectively, are redolent of a conflict of interest. She is an astute, determined woman, convinced of the righteousness of her actions with respect to the ISF and not hesitant to express that conviction (her affidavits are riddled with editorial self justifications). I am wary of acting on her uncorroborated evidence alone. That acknowledged, much bad blood, manifested by much litigation in which they have been on opposing sides, has passed between her and Mr Wilson (or related entities) since March 2004. Even after entering into a comprehensive deed of compromise, of which more shortly, he has demonstrated a degree of recalcitrance in carrying that agreement into effect both in letter and in spirit. However, the efficacy of the releases in that deed as against him are binding and fully apt definitively to eliminate any such residual recalcitrance. In fairness to him, that recalcitrance has been grounded in his perception that, via Ms Hambrook's decision, Interhealth has continued unreasonably to pay out his superannuation benefit entitlement in full. Mr Wilson's recollection of events in March 2004 and thereafter was, I thought, coloured by his recalling them through the prism of his antipathy for Ms Hambrook and that perception.
20 Dr David Williams related in his evidence the elaborate dealings, in which he and Mr Wilson were intimately involved, from 2000 to 2004, directed towards the bringing to fruition of a proposal which would have seen a development not only of Lot 2 and Lot 6 (Bilambil property) but also the intermediate block, Lot 4 Scenic Drive. It is not necessary in order to resolve this case to relate those dealings. His account, which I accept, corroborates Ms Hambrook's recollection of Mr Wilson's involvement in the disposal of the units. Further, the events and related antagonism and litigation, prompted by the discovery by Ms Hambrook and Dr Williams that Lot 6 was registered in Mr Wilson's name, did not occur until later in 2004. I accept Dr Williams' account even though he and his brother Ronald presently share with Ms Hambrook a community of interest in relation to the Bilambil property. The benefits which might potentially be found in a proposal which would have seen the co-operative development of contiguous Lots disparately held make his account inherently likely. I find that, in March 2004, Mr Wilson was not ignorant of the sale of units in the PWUT to TMI. He, along with Ms Hambrook, resolved that Probiotic should sell 50% of the PWUT units to TMI.
21 A consequence of TMI's taking up units in the PWUT was that Dr David Williams joined Ms Hambrook and Mr Wilson on the board of Probiotic. Dr Williams became a director on 7 August 2004. That same month, as he recalls it, he and Ms Hambrook discovered that Lot 6 was not registered in the name of Probiotic but rather Mr Wilson. Ms Hambrook places her discovery of in whose name the Bilambil property was registered as having occurred in "August/September 2004". It seems inherently likely that the occasion for this discovery was their receipt in August of a valuation of the Bilambil property which had been commissioned with a view to Probiotic selling it. That sale was proposed because by then it had become clear that a conjoint development of that property and Lots 2 and 4 Scenic Drive was not possible.
22 Shortly after Ms Hambrook and Dr Williams discovered in whose name the Bilambil property was registered they confronted Mr Wilson on that subject. He claimed that it was a mistake and that he would cause it to be corrected. Notwithstanding repeated requests of him made later in August, in September and in October 2004, he failed to do this. The present acrimony that exists between Mr Wilson and Ms Hambrook dates at least from this time so far as their business relations are concerned but has been much exacerbated by later events. Inferentially, whatever personal relationship they had ceased not later than this time also. It may be that the latter had ceased earlier but this is not clear on the evidence and not necessary in any event to determine for the purpose of resolving these proceedings.
23 An immediate consequence of Mr Wilson's failure to cause the transfer of the Bilambil property to Probiotic was that Ms Hambrook and Dr Williams caused him to be removed as a director of Probiotic in late September 2004. That left the two of them as directors of that company. In November 2004 they caused Probiotic to institute proceedings in number 6294/04 against Mr Wilson in the Supreme Court of New South Wales seeking orders that he cause the Bilambil property to be registered in the name of that company as trustee of the PWUT. That New South Wales proceeding was later cross vested to the Supreme Court of Queensland.
24 As already noted, Mr Wilson ceased in October 2004 to be a director of Interhealth. Ms Hambrook attributed this cessation just to a need to replace Interhealth as trustee of the ISF because that company was also carrying on business in its own right. That is something a trustee of a SMSF should not do. There is certainly contemporaneous correspondence proposing a change of trustee of the ISF for just such a reason and with a replacement by another company of which Mr Wilson and Ms Hambrook would be directors. That proposal never came to pass. Further and in any event, such a reason does not explain why Mr Wilson was removed as a director of Interhealth while that company remained charged with trust and related statutory responsibilities in respect of the ISF. It is no coincidence that this removal occurred at a time of ever increasing acrimony between Ms Hambrook and Mr Wilson and also Dr Williams and Mr Wilson. She was then in a position to cause his removal as a director of Interhealth and did so. Interhealth's shareholders were as to 99.9%, Mr Ron Williams and, as to 0.1%, A.H.A. Group Holdings Pty Ltd (Table 3, WMS Report). On the evidence, Mr Ron Williams and Dr David Williams act in concert in matters touching on Interhealth, Probiotic and the Bilambil property.
25 The effect of the removal of Mr Wilson from the boards of both Interhealth and Probiotic is that he was thereafter excluded from decision-making in respect of the ISF itself and its underlying assets. Between them, Ms Hambrook, Dr David Williams and Mr Ron Williams controlled all of the entities concerned with the ISF and its underlying assets.
26 Separate Queensland Supreme Court de facto relationship property related litigation, matter number BS482/05 was instituted by Mr Wilson in February 2005 against Ms Hambrook, Interhealth, Probiotic, TMI and many other corporate defendants.
27 In the proceeding cross vested to the Queensland Supreme Court, Atkinson J came in March 2006 to make an order, to the making of which Mr Wilson consented, providing for his transferring the Bilambil property to Probiotic. Also in March 2006. and not later than 3 March, Mr Wilson applied to Interhealth for his member's benefit on the basis of age and retirement from employment. Those two events are inherently unlikely to have been coincidental actions on the part of Mr Wilson and I find that they were not.
28 Mr Wilson did not effect the transfer of the Bilambil property to Probiotic until September 2006. Nor for that matter, did Interhealth forthwith pay the member's benefit for which Mr Wilson had applied. On 30 August 2006, Mr Wilson lodged a caveat over the Bilambil property. The basis cited for that caveat was a claimed entitlement on constructive trust arising from his former de facto relationship with Ms Hambrook. This later lapsed but was replaced by a further caveat lodged by relatives of Mr Wilson (his brother in law, Mr Stephen Fitzgerald and his wife and Mr Wilson's sister, Mrs Frances Wilson-Fitzgerald).
29 On 23 August 2007 Mr Wilson instituted proceedings in this Court in matter QUD 271 of 2007 against Ms Hambrook and eventually also Interhealth (in substitution for an original respondent company, seemingly misidentified as the trustee of the ISF) by which he sought to compel payment of his claimed ISF entitlements. None had by then been paid to him by Interhealth. The Commissioner as "Regulator" was once but is no longer also a respondent party to that proceeding. He has though been granted leave to appear as amicus curiae in that proceeding.
30 On 12 November 2007 a comprehensive deed of compromise was made to which Ms Hambrook, Mr Wilson, Interhealth, the relatives of Mr Wilson who had lodged the substitute caveat in respect of the Bilambil property and Probiotic were each party. One of the recitals to that deed was an acceptance by Interhealth that Mr Wilson had retired and was the vested owner of what were described as "the entitlements" and that "subject to the quantum of the entitlements being determined, the entitlements can be paid to [him]". Those entitlements were elsewhere (cl 1.1(p)) defined as "Wilson's Superannuation Entitlements" as "the vested superannuation entitlements payable to Wilson as a consequence of Wilson's retirement and his request that his vested superannuation entitlements be paid to him". Under the deed (cl 5) Mr Wilson released Ms Hambrook, Interhealth and Probiotic from all claims in respect of the Bilambil property. Like comprehensive releases were given to these persons under the deed by Mr Wilson's relatives. The deed further provided (cl 3.1) for the making of an interim distribution of Mr Wilson's ISF superannuation entitlement by way of payment by Interhealth of:
(a) the sum of $150,000 directly to him; and
(b) (implicitly under the deed by Mr Wilson's direction) the amount of a costs order made in favour of Probiotic against Mr Wilson which had become the subject of a Magistrates Court judgment against him together with related enforcement expenses.
31 The deed was also cast on the basis that Interhealth had made application to the Commissioner for the acceptance of an Enforceable Undertaking. What did not occur, prior to the making of interim payments by Interhealth, notwithstanding a qualification with respect to interim payment found in cl 3.1 and cl 3.2 of the deed of compromise, was the appointment of custodians for the purpose undertaking realisations as provided for by a deed of appointment of custodian, a draft of which was attached to the deed of compromise. Nothing was made of the absence of this occurrence in submissions by either party to the present proceeding, presumably on the basis that any such qualifying requirement had been waived by the conduct of all concerned and overtaken by the obligation assumed by Interhealth under the Enforceable Undertaking.
32 The deed of compromise also provided for the taking of accounts and for valuations of the assets of the ISF.
33 As to the taking of accounts and valuations, on 23 November 2007 Mr B McCracken, a registered valuer of Colliers International valued the Bilambil property as at 13 November 2007 at $800,000. This valuation formed part of a report dated 26 November 2007 given to Interhealth by a chartered accountant, Mr I Otto of WMS Legal Support Pty Ltd (the WMS Report), which assessed the value of the net assets of the ISF at $974,822 as at 14 November 2007. The WMS Report is comprehensive. It has been made against the background of Mr Otto's having been briefed with the deed of compromise and details of the cascade of trust and other interests which underpin and intrude upon the superannuation fund's holding of 100% of the units in the GHUT. I accept the opinions as to value contained in the WMS Report and in that of Colliers International, which underpins part of the WMS Report.
34 As disclosed by the WMS Report and as valued by him, the current assets of the ISF as at 14 November 2007 comprised:
(a) Funds in a bank account at the Macquarie Bank - $40,253.00;
(b) Funds held in a term deposit at that same bank - $534,952.00;
(c) A distribution to the ISF receivable from the GHUT - $122,766; and
(d) Amounts receivable from other debtors - $611.
The non-current asset of the ISF comprised the units in the GHUT. Apart from minor tax liabilities, the only then current liabilities of the ISF were the professional fees associated with the preparation of the Colliers valuation and the WMS report. There were no non-current liabilities. No liability in respect of legal expenses was shown in respect of the ISF.
35 In terms of underlying trusts within what I have described as the cascade, the value of the 50% holding by the trustee of the GHUT of the units in the PWUT was given as $337,443 in the WMS Report.
36 A feature of the WMS Report is that its author, Mr Otto, has expressly taken into account when assessing the worth of units in the GHUT a liability to which its trustee was said in its accounts to be subject in respect of legal expenses. Mr Otto proceeded on the basis that they related to the then current litigation in this Court (Para 86 of WMS Report). It may be, as the Commissioner submitted, that some at least of those costs came to be recovered via the payment made by direction as an interim payment under the deed of compromise. It is not necessary to determine that. It is enough to note that the impact of legal costs was taken into account when assessing the worth of what underpinned the assets of the ISF.
37 The accounts of the ISF for the years ended 30 June 2005, 2006, 2007 and 2008 are in evidence (the 2005 accounts also show the comparative 2004 position). For these four financial years, the position so far as the net assets of the ISF and the amounts of Mr Wilson's benefit may be summarised in the following table, subject to the necessary qualification that the 2008 accounts are qualified by the auditors and cast on the basis of ongoing litigation such that there was an inability to pay member benefits. Inferentially, it seems likely that this qualification had its origins in instructions provided by Interhealth's sole director, Ms Hambrook. In any event, I find it impossible to reconcile the qualification with the comprehensive releases contained in the deed of compromise. The 2008 accounts also record a financial year in which member and other payments, related below, were made from the ISF:
Year Liability for Accrued Member's Benefit - allocated to members' account Withdrawal benefit for Mr Wilson
2004 $823,418.17 $431,747.71
2005 $847,164.77 $443,739.51
2006 $876,481.57 $455,440.56
2007 $892,321.67 $442,067.50
2008 $46,832.02 ($30.83)